Table 2.
Study | Study participation22 Representative sample23 Data related to outcome may be different for participants and eligible non-participants/participants selected by random selection or as consecutive cases |
Defined sample23 Description of source of participants and evaluation of inclusion and exclusion criteria |
Study attrition/complete follow-up22 Data related to outcome may be different for completing and non-completing participants |
Outcome measurement22 Measurement of the outcome may be different related to the baseline level |
Study confounding22 Outcome may be distorted by another factor related to outcome |
Statistical analysis and reporting22 Reported results may be spurious or biased related to analysis or reporting |
Provision of data23 Studies must provide raw data, percentages, or continuous outcomes |
Blinded outcome23 Assessor blinded and unaware of other measures at time of outcome was measured |
Overall statement of risk of bias Number of low, moderate and high ratings |
---|---|---|---|---|---|---|---|---|---|
Example study |
Moderate ROB Some eligibility criteria, for example, prolapse <6 mm may contribute to potential participants being excluded Suggests consecutive patients were considered |
Moderate ROB Clear eligibility criteria based on detailed physical examination and radiology findings |
Moderate ROB No losses to follow-up at 6 months 8 (16%) patients lost to follow-up at 12 months |
Low ROB VAS 0–10 in cm Established measurement properties Measure standardised by independent assessor |
Moderate ROB Possible interventions not reported |
Low ROB Sufficient presentation of data No selective reporting of results |
Low ROB Raw data, mean and SD reported |
Low ROB Independent assessor collected data |
Low 4 Moderate 4 High 0 |
Note: prognostic factor section of QUIPS not relevant.
QUIPS, QUality In Prognostic Studies; ROB, risk of bias; VAS, visual analogue scale.